Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

Does Blackbaud’s New Cloud Launch Signal a Shift in Its 2025 Stock Valuation?

Ever wondered if Blackbaud’s stock is hiding untapped value, especially after all the buzz and recent moves in tech? You’re not alone, and today we’re diving in to see what’s really going on with its price tag. Blackbaud jumped 5.4% in the last week and 7.5% over the past month. However, the stock is still down 7.8% this year and 8.5% over twelve months, which suggests changing investor sentiment or the start of a turnaround story. The recent launch of Blackbaud’s new cloud-based solutions...
PSE:SECB
PSE:SECBBanks

Undervalued Small Caps With Insider Actions In Global For October 2025

In October 2025, the global markets have shown resilience with U.S. small-cap indices like the Russell 2000 and S&P MidCap 400 outperforming their large-cap peers, despite ongoing geopolitical tensions and economic uncertainties. As inflation trends lower than expected and business activity accelerates, investors are increasingly focusing on small-cap stocks that demonstrate strong fundamentals and potential for growth in this dynamic environment.
KOSE:A003230
KOSE:A003230Food

Global Market Insights: 3 Stocks Including Türkiye Is Bankasi That May Be Priced Below Estimated Value

In recent weeks, global markets have shown resilience amid fluctuating economic indicators, such as lower-than-expected U.S. inflation and strengthening business activity in the Eurozone. As investors navigate these complex conditions, identifying undervalued stocks becomes crucial; this involves seeking opportunities where market prices may not fully reflect a company's intrinsic value or growth potential.
NYSE:CWH
NYSE:CWHSpecialty Retail

Camping World (CWH): Deep Discount to Fair Value Reinforces Bullish Narrative Despite Worsening Losses

Camping World Holdings (CWH) remains unprofitable, with losses compounding at a rapid 53.3% per year over the last five years. Looking ahead, analysts see a sharp turnaround, forecasting earnings to grow at an exceptional 187.51% annually and shifting the company into profitability within three years. This is happening even as revenue growth of 5.7% per year trails the wider US market's 10.2% pace. The stock is currently trading at $12.65, well beneath its estimated fair value of $28.50, and...
NYSE:SEMR
NYSE:SEMRSoftware

Is Semrush Stock a Hidden Opportunity After Recent Platform Enhancements and Share Price Drop?

Wondering whether Semrush Holdings stock is a hidden gem or just another falling knife? Let's dive in and find out if there's real value beneath the surface. The share price has seen some turbulence, dropping 4.1% in the last week and down nearly 38% year-to-date. This signals shifting expectations around growth and risk. Recent headlines have focused on Semrush’s product enhancements, including expansions to their digital marketing platform and new partnerships. These developments have...
NYSE:CHCT
NYSE:CHCTHealth Care REITs

Community Healthcare Trust (CHCT) Losses Accelerate, Testing Bullish Valuation Narratives

Community Healthcare Trust (CHCT) remains in the red, posting another year of losses that have accelerated at an annual rate of 49.5% over the past five years. Despite this track record, the company is guiding for a sharp turnaround with earnings forecast to grow by 55.06% per year and potentially swing into profitability within three years. Revenue is expected to rise 9% annually, which is slightly behind the broader US market’s 10.2% pace. Shares currently trade at $14.43, well below a...
NYSE:AROC
NYSE:AROCEnergy Services

Archrock (AROC): Profit Soars 83%, Margin Jump Reinforces Bullish Narratives Ahead of Earnings

Archrock (AROC) posted standout earnings, with profits rising at a 58.3% annual rate over the past five years and surging 83.2% in the latest year, well ahead of its longer-term trend. Net profit margins also improved to 18.3%, up from 13.1% last year, while analysts expect earnings to grow 13.04% per year going forward, a pace that trails the broader US market. Investors see the combination of accelerating profitability, higher margins, and shares trading below fair value as supportive;...
OM:VBG B
OM:VBG BMachinery

VBG Group (OM:VBG B) Margin Decline Challenges Historical Growth Narrative

VBG Group (OM:VBG B) reported a net profit margin of 7.9%, down from 10.6% a year ago, diverging from its strong five-year earnings growth trend of 16.3% per year. Despite the recent dip, earnings are forecast to climb 17.4% annually and revenue is expected to grow at 6.8% per year, both outpacing Swedish market averages. With attractive valuation metrics and earnings momentum projected to pick up, investors have reason to focus on the growth outlook. However, recent margin compression and a...
NasdaqGS:FYBR
NasdaqGS:FYBRTelecom

Frontier (FYBR) Losses Deepen 49.9% Annually, Challenging Hopes for Turnaround

Frontier Communications Parent (FYBR) is still in the red, with losses having accelerated at an average annual rate of 49.9% over the past five years. While revenue is forecast to grow only 2.9% per year, well behind the US market’s 10.2% average, the company's net profit margin has not improved and forecasts suggest ongoing unprofitability for the next three years. Despite trading below its calculated fair value of $93.64 at a recent price of $37.73, FYBR remains relatively expensive against...
BME:IBE
BME:IBEElectric Utilities

Iberdrola (BME:IBE) Margin Dip Challenges Bull Case Despite Outpacing Spanish Earnings Growth

Iberdrola (BME:IBE) posted 11% annual profit growth over the past five years and is now forecast to grow earnings at 7.7% per year, outpacing the Spanish market’s expected 4.7% rate. However, recent results reveal net profit margins have slipped to 11.5%, down from last year's 14.3%, and revenue growth is projected at a slightly softer 4.5% per year, trailing the broader market. With margins narrowing and revenue forecasts lagging, investors are likely to focus on operational performance for...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Alkermes (ALKS) Margin Decline to 22.2% Challenges Bullish Narratives Despite Value Appeal

Alkermes (ALKS) reported revenue growth of 7% per year, trailing the broader US market average of 10.2% annually. Net profit margins came in at 22.2%, down from last year’s 25.7%. Earnings are projected to decline at an average rate of 11.1% per year over the next three years. Despite the cautious near-term outlook, the company’s five-year record shows it has become profitable, with historical earnings growth averaging 56.4% per year and a consistent track of high-quality earnings that...
NYSE:MIR
NYSE:MIRElectronic

Mirion Technologies (MIR): One-Off $10.8M Loss Casts Doubt on Strong Profit Growth Narrative

Mirion Technologies (MIR) turned profitable in the past year, posting five-year annualized earnings growth of 34.5% and a forecasted leap of 63.9% per year moving forward. This far outpaces both its own history and the US market's average 15.6% growth rate. Revenue is projected to rise 15.9% annually, topping the US market’s 10.2% rate, even as a one-off $10.8 million loss weighed on recent results. With the share price trading at $29.75, above its estimated fair value, investors are...
NYSE:TTI
NYSE:TTIEnergy Services

TETRA Technologies (TTI) Net Profit Margin Surges to 19.7%, Challenging Earnings Quality Concerns

TETRA Technologies (TTI) has delivered headline-grabbing earnings, with net profit margin soaring to 19.7% compared to just 1.2% last year. Over the last five years, the company has shifted to profitability, compounding earnings at an impressive 73.5% annual rate, and most recently accelerating with a staggering 1601.9% earnings growth in the past year. However, despite these strong numbers, investors face a mixed outlook as revenue growth is expected to lag the broader market at 7.9% per...
SEHK:412
SEHK:412Renewable Energy

Shandong Hi-Speed Holdings Group (SEHK:412) Faces Index Removal—How Might This Shape Its Market Perception?

On October 27, 2025, Shandong Hi-Speed Holdings Group Limited was removed from the Hang Seng China Affiliated Corporations Index, a development affecting its visibility among major investors. Index changes such as this one often prompt large institutional portfolio adjustments, reflecting the importance of index membership in shaping investment activity and stock demand. We’ll explore how Shandong Hi-Speed Holdings Group’s removal from the index could reshape investors’ perception of its...
NYSE:HRI
NYSE:HRITrade Distributors

Herc Holdings (HRI): Projected 10.6% Annual Revenue Growth Sets Focus on Profitability Path

Herc Holdings (HRI) is currently unprofitable, but the company cut its losses by 2% per year over the past five years and is forecast to achieve robust revenue growth of 10.6% annually, just above the US market’s 10.2% average. Earnings are projected to climb 48.32% per year, and HRI is expected to reach profitability within the next three years. With these forecasts and a focus on future earnings momentum, many investors may see this as a meaningful pivot point for the company’s performance...
TSX:CG
TSX:CGMetals and Mining

Centerra Gold (TSX:CG) One-Off Gain Lifts Profit Margin, Challenges Quality of Earnings Narratives

Centerra Gold (TSX:CG) reported a one-off gain of $288.0 million over the past twelve months to September 30, 2025, which drove its net profit margin up to 26.4%. This marks a significant jump from last year’s 8.3%. Earnings surged 225.3% year-over-year, a sharp turnaround from the company’s 5-year average decline of -12.3% per year. Profit margins and earnings have both seen marked improvements as Centerra returned to profitability. Investors are now weighing strong headline numbers and...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Arcutis Biotherapeutics (ARQT): Projected 24% Annual Revenue Growth Shapes Value Narrative Ahead of Earnings

Arcutis Biotherapeutics (ARQT) remains unprofitable but has managed to shrink its losses over the last five years, recording a 3.3% annual rate of improvement. The company’s revenue is projected to grow at 24% per year, notably faster than the US market average of 10.2%. With a negative net profit margin but a favorable Price-to-Sales Ratio of 9.7x, trading well below biotech peers and the broader industry, Arcutis offers a compelling risk and reward setup focused squarely on strong growth...